Neuragen PN (Origin Biomed Inc)


Welcome to the PulseAid listing for the Neuragen PN drug offered from Origin Biomed Inc. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Origin Biomed Inc
NON-PROPRIETARY NAME: Aconitum napellus, Hypericum perforatum, Lycopodium clavatum, Phosphorus, Rhus toxicodendron, Secale cornutum
SUBSTANCE NAME: HYPERICUM PERFORATUM; ACONITUM NAPELLUS; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; TOXICODENDRON PUBESCENS LEAF; CLAVICEPS PURPUREA SCLEROTIUM
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2005-08-01
END MARKETING DATE: 0000-00-00


Neuragen PN HUMAN OTC DRUG Details:

Item DescriptionNeuragen PN from Origin Biomed Inc
LABELER NAME: Origin Biomed Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 12; 12; 12; 12; 12; 12([hp_C]/15mL; [hp_C]/15mL; [hp_C]/15mL; [hp_C]/15mL; [hp_C]/15mL; [hp_C]/15mL)
START MARKETING DATE: 2005-08-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 15377-002_9162ac36-62de-4d2c-bf16-c84045016264
PRODUCT NDC: 15377-002
APPLICATION NUMBER:

Other HYPERICUM PERFORATUM; ACONITUM NAPELLUS; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; TOXICODENDRON PUBESCENS LEAF; CLAVICEPS PURPUREA SCLEROTIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Origin Biomed IncNeuragen PN